The finding suggests the government has met its target of getting UK clinical trials up and running within an average of 150 ...

The British Business Bank (BB) has agreed to make a £100 million investment in a new healthcare fund launched by London-based ...

With one approved drug (Johnson & Johnson’s Spavaro) already doing $468 million per quarter in sales, and with companies like ...

The report from the influential Cochrane Collaboration, an independent group that independently analyses clinical data, ...

The ABPI, in the 3 rd March blog by Pinchas Kahtan, highlighted “early signs of a modest recovery in clinical trial ...

Berkeley Heights, NJ – April 15, 2026: Axtria Inc., a global leader in AI-first data analytics solutions for the life ...

Eli Lilly says it has the safety data it needs to shore up the recent speedy approval of its oral obesity therapy Foundayo, ...

That's the conclusion of a just-published report (PDF) from the influential Institute for Clinical and Economic Review (ICER) ...

Saqib Islam, chief executive Officer of newly launched Beeline Medicines. The pace of private financing in biopharma steps up ...

Despite billions spent on new technology and improving data analytics, companies continue to struggle with commercial launch ...

Japanese pharma group Daiichi Sankyo has reached a deal to sell its consumer healthcare division to food and beverage giant ...

The FDA may have approved Eli Lilly's oral weight-loss drug Foundayo in record time, but it still needs to see more safety ...